The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Not Applicable
Completed
- Conditions
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Interventions
- Device: 80 lead ECG
- Registration Number
- NCT02291393
- Lead Sponsor
- The Leeds Teaching Hospitals NHS Trust
- Brief Summary
The diagnosis of Arrhythmogenic right ventricular cardiomyopathy can be difficult. The 80 lead ECG may increase the specificity and sensitivity in diagnosing this potentially life threatening inherited cardiac condition. This pilot would form the basis of a much larger clinical trial to test the utility of this novel diagnostic tool.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Patients with a confirmed diagnosis of arrhythmogenic right ventricular cardiomyopathy who are being followed up in the cardiology clinic
Exclusion Criteria
- Inability to consent
- Pacing dependent patients
- Other concomitant cardiag disease e.g. coronary artery disease
- Atrial fibrillation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Healthy volunteers 80 lead ECG Aged and gender matched healthy controls. Patient 80 lead ECG Patients with previously confirmed Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- Primary Outcome Measures
Name Time Method QRS wave dispersion in an ECG 5 minutes The difference in QRS wave dispersion between the right and left ventricular leads
- Secondary Outcome Measures
Name Time Method